To further confirm the results that HFD+CKD–increased CASP11 activation in aortas compared with the other groups, we used the CASP11 activity assay and found that CASP11 activity in HFD+CKD aorta was higher than that of CKD and HFD-sham (Figure 2H). This evidence concerns the gene SCAF11 and chronic kidney disease.